Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody is a research paper published in Virology (2021). On theSindex it has a DataRank of 0.564. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R01 AI132668
NIAID NIH HHS
Grant: R01 AI140442
NIAID NIH HHS
Grant: T32 AI162691
NIBIB NIH HHS
Grant: R01 EB031510
National Institutes of Health
Grant: 5R01AI132668-03
Mechanism of Flavivirus RNA Capping
National Institutes of Health
Grant: 5R01AI140442-02
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins
National Institutes of Health
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals